Evaluation of Bladder Cancer
Home Back

 

 Home

 Site Map               

 Index                     

 Prostate Cancer  

 Urologic  Diseases
 Facility Map &    

       Addresses    

 Research               

 Doctors & NP's      

 ErectileDysfunction

 Prostatitis              

 Incontinence         

 Kidney Stones

 

 

 

 

What is Bladder Cancer

Blood in Urine

Causes of Bladder Cancer

Symptoms of BlCa

Pathology of BlCa

Prognosis of BlCa

Treatment of BlCa

     Resection / TURBT

     Rx Superficial Ta-T1

          BCG

     Rx Invasive T2-T4

          Radical Cystectomy

          Bladder Sparing

          Urinary Diversion

              Ileal Loop

              Continent Diversion

              Neobladder

     Rx Metastatic N+ M+

              Chemotherapy

 

 

 

 

What diagnostic tests are used?

Cystoscopy is the definitive test for diagnosing bladder cancer.  Under local anesthesia or sedation, a telescope is inserted into the bladder through the urethra and the urologist can look around the bladder.  Frequently a tumor will be seen in the bladder.  The urologist may want to take a small piece of it, (biopsy), to examine under the microscope,  More likely he will not biopsy at this time, but schedule the patient for a procedure to remove the tumor.

Biopsy or microscopic examination of the abnormal tissues found in the bladder is the only way to make the diagnosis of bladder cancer.  Specimens for biopsy may be obtained at time of cystoscopy, or at the removal of the tumor.

Cytology is the examination of urine under the microscope to look for cancerous cells.  While it is a helpful test, many false positive and false negative tests may occur, so a cytological examination can not always make or eliminate the diagnosis of bladder cancer.

Upper Tract Studies such as IVP, (x-rays taken after a contrast medium is injected into a vein, that "lights up" the kidneys and ureters), or CT scan, or retrograde pyelograms done during cystoscopy, are adjunctive tests that help diagnose cancer in the ureters or kidneys, (upper tracts), but only show bladder cancer about 30% of the time.

NMP22, BTA-Stat, FDP  Newer, voided urine assays  examines the urine for an abnormal proteins associated with bladder cancer.  They have many false negatives and are much more useful for following patients in whom the diagnosis of bladder cancer has already been made rather than in making the initial diagnosis of bladder cancer

rev:01/02

                    [Top] [Pathology] [Next]

         [Home]

Werner - Francis Urology Associates llc - Mid Atlantic Urology Associates llc

Greenbelt - Bowie - Laurel     Maryland

(301) 441-8900               Fax (301) 982 0453

7500 Hanover Parkway   Suite 206    Greenbelt, MD   20770

e-mail: wfurology@gmail.com

contact us

                                                                                   

Rev:03/08